HLA-G as a tolerogenic molecule in transplantation and pregnancy

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Rebmann, Vera ^a   Da Silva Nardi, Fabiola ^a,b   Wagner, Bettina ^a   Horn, Peter A ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b MINISTRY OF EDUCATION OF BRAZIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; IMMUNOGLOBULIN RECEPTOR; PROTEIN BINDING;

ALLOGRAFT; ALLOTRANSPLANTATION; FEMALE; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOLECULAR RECOGNITION; PREGNANCY; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; TRANSPLANTATION; GENE EXPRESSION REGULATION; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM;

FEMALE; GENE EXPRESSION REGULATION; HLA-G ANTIGENS; HUMANS; IMMUNE TOLERANCE; PREGNANCY; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; REPRODUCTION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84929138332     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/297073     Document Type: Review

References (193)

1. J. Robinson, J. A. Halliwell, H. McWilliam, R. Lopez, P. Parham, and S. G. E. Marsh, "The IMGT/HLA database, " Nucleic Acids Research, vol. 41, no. 1, pp. D1222-D1227, 2013.
2. N. Lee, A. R. Malacko, A. Ishitani, et al., "Themembrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association, " Immunity, vol. 3, no. 5, pp. 591-600, 1995.
3. H. Nuckel, E. C. Castelli, P. Moreau, C. Ochsenfarth, P. A. Horn, and V. Rebmann, "Simple methods for the detection of HLA-G variants in coding and non-coding regions, " Methods in Molecular Biology, vol. 882, pp. 123-142, 2012.
4. P. Paul, F. A. Cabestre, E. C. Ibrahim, et al., "Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells, " Human Immunology, vol. 61, no. 11, pp. 1138-1149, 2000.
5. T. Fujii, A. Ishitani, and D. E. Geraghty, "A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4, " Journal of Immunology, vol. 153, no. 12, pp. 5516-5524, 1994.
6. A. Ishitani and D. E. Geraghty, "Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens, " Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 9, pp. 3947-3951, 1992.
7. D. E. Geraghty, B. H. Koller, and H. T. Orr, "A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment., " Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 24, pp. 9145-9149, 1987.
8. J. M. Houlihan, P. A. Biro, H. M. Harper, H. J. Jenkinson, and C. H. Holmes, "The human amnion is a site of MHC class Ib expression: Evidence for the expression of HLA-E and HLA-G, " Journal of Immunology, vol. 154, no. 11, pp. 5665-5674, 1995.
9. A. Hammer, H. Hutter, A. Blaschitz, et al., "Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G, " American Journal of Reproductive Immunology, vol. 37, no. 2, pp. 161-171, 1997.
10. C. Menier, M. Rabreau, J. Challier, M. Le Discorde, E. D. Carosella, and N. Rouas-Freiss, "Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis, " Blood, vol. 104, no. 10, pp. 3153-3160, 2004.
11. A. Blaschitz, F. Lenfant, V. Mallet, et al., "Endothelial cells in chorionic fetal vessels of first trimester placenta express HLAG, " European Journal of Immunology, vol. 27, no. 12, pp. 3380-3388, 1997.
12. L. Crisa, M. T. McMaster, J. K. Ishii, S. J. Fisher, and D. R. Salomon, "Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts, " The Journal of Experimental Medicine, vol. 186, no. 2, pp. 289-298, 1997.
13. M. Le Discorde, P. Moreau, P. Sabatier, J. Legeais, and E. D. Carosella, " Expression of HLA-G in human cornea, an immune-privileged tissue, " Human Immunology, vol. 64, no. 11, pp. 1039-1044, 2003.
14. V. Cirulli, J. Zalatan, M. McMaster, et al., "The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G, " Diabetes, vol. 55, no. 5, pp. 1214-1222, 2006.
15. T. Ito, N. Ito, M. Saathoff, et al., "Immunology of the human nail apparatus: the nailmatrix is a site of relative immune privilege, " TheJournal of InvestigativeDermatology, vol. 125, no. 6, pp. 1139-1148, 2005.
16. M. Ulbrecht, B. Rehberger, I. Strobel, et al., "HLA-G: expression in human keratinocytes in vitro and in human skin in vivo, " European Journal of Immunology, vol. 24, no. 1, pp. 176-180, 1994.
17. V. Rebmann, K. Pfeiffer, M. Paler, et al., "Detection of soluble HLA-G molecules in plasma and amniotic fluid, " Tissue Antigens, vol. 53, no. 1, pp. 14-22, 1999.
18. V. Rebmann, A. Busemann, M. Lindemann, and H. Grosse-Wilde, "Detection ofHLA-G5 secreting cells, "Human Immunology, vol. 64, no. 11, pp. 1017-1024, 2003.
19. V. Rebmann, J. LeMaoult, N. Rouas-Freiss, E. D. Carosella, and H. Grosse-Wilde, "Report of theWetWorkshop for quantification of soluble HLA-G in Essen, 2004, " Human Immunology, vol. 66, no. 8, pp. 853-863, 2005.
20. L. Zhao, B. Purandare, J. Zhang, and B. M. Hantash, " β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production, " Human Immunology, vol. 74, no. 4, pp. 417-424, 2013.
21. T. Gonen-Gross, D. Goldman-Wohl, B. Huppertz, et al., "Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetalmaternal interface, " PLoS ONE, vol. 5, no. 1, Article ID e8941, 2010.
22. A. Arnaiz-Villena, J. Martinez-Laso, J. I. Serrano-Vela, R. Reguera, and J. Moscoso, "HLA-G polymorphism and evolution, " Tissue Antigens, vol. 69, supplement 1, pp. 156-159, 2007.
23. J. E. Boyson, R. Erskine, M. C. Whitman, et al., "Disulfide bond-mediated dimerization of HLA-G on the cell surface, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16180-16185, 2002.
24. M. Shiroishi, K. Kuroki, L. Rasubala, et al., "Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d), " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 44, pp. 16412-16417, 2006.
25. K. Y. HoWangYin, M. Loustau, J. Wu, et al., "Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors, " Cellular and Molecular Life Sciences, vol. 69, no. 23, pp. 4041-4049, 2012.
26. E. Alegre, V. Rebmann, J. Lemaoult, et al., "In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes, " European Journal of Immunology, vol. 43, no. 7, pp. 1933-1939, 2013.
27. B. Riteau, F. Faure, C. Menier, et al., "Exosomes Bearing HLA-G are Released byMelanoma Cells, " Human Immunology, vol. 64, no. 11, pp. 1064-1072, 2003.
28. M. Colonna, F. Navarro, T. Bellon, et al., "A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells, " The Journal of Experimental Medicine, vol. 186, no. 11, pp. 1809-1818, 1997.
29. S. Rajagopalan and E. O. Long, "A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells, " Journal of Experimental Medicine, vol. 189, no. 7, pp. 1093-1100, 1999.
30. D. Saverino, M. Fabbi, F. Ghiotto, et al., "The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions, " Journal of Immunology, vol. 165, no. 7, pp. 3742-3755, 2000.
31. A. H. Banham, M. Colonna, M. Cella, et al., "Identification of the CD85 antigen as ILT2, an inhibitoryMHC class I receptor of the immunoglobulin superfamily, " Journal of Leukocyte Biology, vol. 65, no. 6, pp. 841-845, 1999.
32. D. L. Lamar, C. M. Weyand, and J. J. Goronzy, "Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages, " Blood, vol. 115, no. 16, pp. 3278-3286, 2010.
33. M. Colonna, J. Samaridis, M. Cella, et al., "Cutting edge: humanmyelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I-molecules, " Journal of Immunology, vol. 160, no. 7, pp. 3096-3100, 1998.
34. C. S. Clements, L. Kjer-Nielsen, J. McCluskey, and J. Rossjohn, "Structural studies on HLA-G: implications for ligand and receptor binding, " Human Immunology, vol. 68, no. 4, pp. 220-226, 2007.
35. A. Verloes, H. van de Velde, J. leMaoult, et al., "HLA-G expression in human embryonic stem cells and preimplantation embryos, " Journal of Immunology, vol. 186, no. 4, pp. 2663-2671, 2011.
36. W. H. Yan and L. A. Fan, "Residues Met76 and Gln79 in HLAG 1 domain involved in KIR2DL4 recognition, " Cell Research, vol. 15, no. 3, pp. 176-182, 2005.
37. J. P. Goodridge, C. S. Witt, F. T. Christiansen, and H. S. Warren, "KIR2DL4 (CD158d) genotype influences expression and function in NK cells, " Journal of Immunology, vol. 171, no. 4, pp. 1768-1774, 2003.
38. A. Kikuchi-Maki, S. Yusa, T. L. Catina, and K. S. Campbell, "KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-β production, " Journal of Immunology, vol. 171, no. 7, pp. 3415-3425, 2003.
39. N. M. Valiante, M. Uhrberg, H. G. Shilling, et al., "Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors, " Immunity, vol. 7, no. 6, pp. 739-751, 1997.
40. Y. R. Yu, X. H. Tian, Y. Wang, and M. F. Feng, "Rapidproduction of human KIR2DL4 extracellular domain and verification of its interaction with HLA-G, " Biochemistry Biokhimiia, vol. 71, supplement 1, pp. S60-S65, 2006.
41. S. Rajagopalan, Y. T. Bryceson, S. P. Kuppusamy, et al., "Activation ofNKcells by an endocytosed receptor for solubleHLA-G, " PLoS Biology, vol. 4, article e9, 2006.
42. S. Rajagopalan, J. Fu, and E. O. Long, "Cutting edge: induction of IFN-β production but not cytotoxicity by the killer cell Iglike receptor KIR2DL4 (CD158d) in resting NK cells, " Journal of Immunology, vol. 167, no. 4, pp. 1877-1881, 2001.
43. M. E. Le Page, J. P. Goodridge, E. John, F. T. Christiansen, and C. S. Witt, "Response to comment on "Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-gamma responses to soluble HLA-G preparations, " The Journal of Immunology, vol. 192, no. 9, pp. 4003-4004, 2014.
44. M. Brusilovsky, M. Cordoba, B. Rosental, et al., "Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses, " The Journal of Immunology, vol. 191, no. 10, pp. 5256-5267, 2013.
45. S. K. Sanders, P. A. Giblin, and P. Kavathas, "Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts, " The Journal of Experimental Medicine, vol. 174, no. 3, pp. 737-740, 1991.
46. P. Contini, M. Ghio, A. Poggi, et al., "Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation, " European Journal of Immunology, vol. 33, no. 1, pp. 125-134, 2003.
47. S. Fournel, M. Aguerre-Girr, X. Huc, et al., "Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8, " Journal of Immunology, vol. 164, no. 12, pp. 6100-6104, 2000.
48. C. Solier, M. Aguerre-Girr, F. Lenfant, et al., "Secretion of proapoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast, " European Journal of Immunology, vol. 32, no. 12, pp. 3576-3586, 2002.
49. M. Llano, N. Lee, F. Navarro, et al., "HLA-E-bound peptides influence recognition by inhibitory and triggeringCD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer, " European Journal of Immunology, vol. 28, pp. 2854-2863, 1998.
50. G. Curigliano, C. Criscitiello, L. Gelao, and A. Goldhirsch, "Molecular pathways: human leukocyte antigen G (HLA-G), " Clinical Cancer Research, vol. 19, pp. 5564-5571, 2013.
51. S. Le Rond, C. Azema, I. Krawice-Radanne, et al., "Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells, " The Journal of Immunology, vol. 176, no. 5, pp. 3266-3276, 2006.
52. S. Gregori, C. F. Magnani, and M. G. Roncarolo, "Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells, " Human Immunology, vol. 70, no. 12, pp. 966-969, 2009.
53. N. Rouas-Freiss, A. Naji, A. Durrbach, and E. D. Carosella, "Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation, " Transplantation, vol. 84, pp. S21-S25, 2007.
54. M. Ponte, C. Cantoni, R. Biassoni, et al., "Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 10, pp. 5674-5679, 1999.
55. B. Riteau, N. Rouas-Freiss, C. Menier, P. Paul, J. Dausset, and E. D. Carosella, "HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigenspecific CTL cytolysis, " Journal of Immunology, vol. 166, no. 8, pp. 5018-5026, 2001.
56. N. Rouas-Freiss, R. E. Marchal, M. Kirszenbaum, J. Dausset, and E. D. Carosella, "The 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?" Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 10, pp. 5249-5254, 1997.
57. N. Rouas-Freiss, R. M. Gonclves, C. Menier, J. Dausset, and E. D. Carosella, "Direct evidence to support the role of HLAG in protecting the fetus from maternal uterine natural killer cytolysis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 21, pp. 11520-11525, 1997.
58. B. Riteau, C. Menier, I. Khalil-Daher, et al., "HLA-G inhibits the allogeneic proliferative response, " Journal of Reproductive Immunology, vol. 43, no. 2, pp. 203-211, 1999.
59. F. Ketroussi, M. Giuliani, R. Bahri, B. Azzarone, B. Charpentier, and A. Durrbach, "Lymphocyte cell-cycle inhibition by HLAG is mediated by phosphatase SHP-2 and acts on the mTOR pathway, " PLoS ONE, vol. 6, no. 8, Article ID e22776, 2011.
60. R. Bahri, F. Hirsch, A. Josse, et al., "Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes, " Journal of Immunology, vol. 176, no. 3, pp. 1331-1339, 2006.
61. A. Naji, C. Menier, F. Morandi, et al., "Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses, " The Journal of Immunology, vol. 192, no. 4, pp. 1536-1546, 2014.
62. T. Kanai, T. Fujii, N. Unno, et al., "Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood, " The American Journal of Reproductive Immunology, vol. 45, no. 2, pp. 94-99, 2001.
63. T. Kanai, T. Fujii, S. Kozuma, et al., "Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture, " Molecular Human Reproduction, vol. 7, no. 2, pp. 195-200, 2001.
64. S. Liang, B. Baibakov, and A. Horuzsko, "HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor, " European Journal of Immunology, vol. 32, pp. 2418-2426, 2002.
65. S. Liang, V. Ristich, H. Arase, J. Dausset, E. D. Carosella, and A. Horuzsko, "Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 24, pp. 8357-8362, 2008.
66. W. Zhang, S. Liang, J. Wu, and A. Horuzsko, "Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts, " Transplantation, vol. 86, no. 8, pp. 1125-1134, 2008.
67. J. LeMaoult, I. Krawice-Radanne, J. Dausset, and E. D. Carosella, "HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 18, pp. 7064-7069, 2004.
68. S. Gregori, D. Tomasoni, V. Pacciani, et al., "Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway, " Blood, vol. 116, pp. 935-944, 2010.
69. M. Rossetti, S. Gregori, and M. G. Roncarolo, "Granulocytecolony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naive T cells, " European Journal of Immunology, vol. 40, no. 11, pp. 3097-3106, 2010.
70. G. Amodio, A. Mugione, A. M. Sanchez, et al., "HLA-G expressing DC-10 and CD4+ T cells accumulate in human decidua during pregnancy, " Human Immunology, vol. 74, no. 4, pp. 406-411, 2013.
71. Y. Q. Yao, D. H. Barlow, and I. L. Sargent, "Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses, " Journal of Immunology, vol. 175, no. 12, pp. 8379-8385, 2005.
72. V. R. Shaikly, I. E. G. Morrison, M. Taranissi, et al., "Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression, " Journal of Immunology, vol. 180, no. 6, pp. 4330-4337, 2008.
73. A. Jurisicova, R. F. Casper, N. J. MacLusky, and C. L. Librach, "Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development, " Fertility and Sterility, vol. 65, no. 5, pp. 997-1002, 1996.
74. A. Jurisicova, R. F. Casper, N. J. Maclusky, G. B. Mills, and C. L. Librach, "HLA-G expression during preimplantation human embryo development, " Proceedings of the National Academy of Sciences of theUnited States of America, vol. 93, no. 1, pp. 161-165, 1996.
75. A. Gonzlez, V. Rebmann, J. Lemaoult, P. A. Horn, E. D. Carosella, and E. Alegre, "The immunosuppressive molecule HLA-Gand its clinical implications, " Critical Reviews in Clinical Laboratory Sciences, vol. 49, no. 3, pp. 63-84, 2012.
76. R. Rizzo, M. Vercammen, H. van de Velde, P. A. Horn, and V. Rebmann, "The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells, " Cellular and Molecular Life Sciences, vol. 68, no. 3, pp. 341-352, 2011.
77. M. Dahl and T. V. F. Hviid, "Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss, " Human Reproduction Update, vol. 18, no. 1, pp. 92-109, 2012.
78. V. Rebmann, M. Switala, I. Eue, and H. Grosse-Wilde, "Soluble HLA-Gis an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study, " Human Reproduction, vol. 25, no. 7, pp. 1691-1698, 2010.
79. A. Ishitani, N. Sageshima, and K. Hatake, "The involvement of HLA-E and -F in pregnancy, " Journal of Reproductive Immunology, vol. 69, no. 2, pp. 101-113, 2006.
80. A. Ishitani, N. Sageshima, N. Lee, et al., "Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition, " Journal of Immunology, vol. 171, no. 3, pp. 1376-1384, 2003.
81. R. G. Roussev and C. B. Coulam, "HLA-G and its role in implantation (review), " Journal of Assisted Reproduction and Genetics, vol. 24, no. 7, pp. 288-295, 2007.
82. R. Apps, L. Gardner, A. M. Sharkey, N. Holmes, and A. Moffett, "A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1, " European Journal of Immunology, vol. 37, no. 7, pp. 1924-1937, 2007.
83. P. J. Morales, J. L. Pace, J. S. Platt, D. K. Langat, and J. S. Hunt, "Synthesis of β2-microglobulin-free, disulphide-linked HLAG5 homodimers in human placental villous cytotrophoblast cells, " Immunology, vol. 122, no. 2, pp. 179-188, 2007.
84. L. Lombardelli, M. Aguerre-Girr, F. Logiodice, et al., "Piccinni MP: HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4(+) T cells and macrophages, " Journal of Immunology, vol. 191, pp. 3651-3662, 2013.
85. Y. H. Huang, A. L. Zozulya, C. Weidenfeller, et al., "Specific central nervous system recruitment of HLA-G+ regulatory T cells in multiple sclerosis, " Annals of Neurology, vol. 66, no. 2, pp. 171-183, 2009.
86. D. S. Goldman-Wohl, I. Ariel, C. Greenfield, et al., "Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia, " Molecular Human Reproduction, vol. 6, no. 1, pp. 88-95, 2000.
87. A. Farina, C. Zucchini, P. De Sanctis, et al., "Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop pre-eclampsia later in pregnancy: implications for screening, " Prenatal Diagnosis, vol. 31, no. 2, pp. 181-185, 2011.
88. N. Hara, T. Fujii, T. Yamashita, S. Kozuma, T. Okai, and Y. Taketani, "Altered expression of human leukocyte antigen g (HLA-G) on extravillous trophoblasts in preeclampsia: Immunohistological demonstration with anti-HLA-G specific antibody "87G" and anti-cytokeratin antibody CAM5. 2, " The American Journal of Reproductive Immunology, vol. 36, no. 6, pp. 349-358, 1996.
89. S. M. Yie, L. H. Li, Y. M. Li, and C. Librach, "HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia, "The American Journal of Obstetrics and Gynecology, vol. 191, no. 2, pp. 525-529, 2004.
90. J. S. Hunt, L. Jadhav, W. Chu, D. E. Geraghty, and C. Ober, "Soluble HLA-G circulates in maternal blood during pregnancy, " The American Journal of Obstetrics and Gynecology, vol. 183, no. 3, pp. 682-688, 2000.
91. E. Alegre, A. Diaz-Lagares, J. LeMaoult, N. Lopez-Moratalla, E. D. Carosella, and A. Gonzalez, "Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy, "Human Immunology, vol. 68, no. 8, pp. 661-667, 2007.
92. R. Hackmon, M. Hallak, M. Krup, et al., "HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy, " Fetal Diagnosis and Therapy, vol. 19, no. 5, pp. 404-409, 2004.
93. J. P. Kusanovic, R. Romero, C. Jodicke, et al., "Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation, " Journal of Maternal-Fetal and Neonatal Medicine, vol. 22, no. 12, pp. 1151-1166, 2009.
94. N. Lila, A. Carpentier, C. Amrein, I. Khalil-Daher, J. Dausset, and E. D. Carosella, "Implication of HLA-G molecule in heartgraft acceptance, " The Lancet, vol. 355, no. 9221, p. 2138, 2000.
95. N. Lila, C. Amrein, R. Guillemain, et al., "Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection, " Circulation, vol. 105, no. 16, pp. 1949-1954, 2002.
96. J. Luque, M. I. Torres, M. D. Aumente, et al., "Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy, " Human Immunology, vol. 67, no. 4-5, pp. 257-263, 2006.
97. R. Sheshgiri, V. Rao, A. Mociornita, H. J. Ross, and D. H. Delgado, "Association between HLA-G expression and C4d staining in cardiac transplantation, " Transplantation, vol. 89, no. 4, pp. 480-481, 2010.
98. N. Lila, N. Rouas-Freiss, J. Dausset, A. Carpentier, and E. D. Carosella, "Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatorymechanism, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 21, pp. 12150-12155, 2001.
99. R. M. Blanco-Garcia, M. R. Lopez-alvarez, I. P. Garrido, et al., "Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy, " Human Immunology, vol. 74, no. 3, pp. 318-324, 2013.
100. A. G. Mociornita, J. Lim-Shon, J. M. Joseph, H. J. Ross, V. Rao, and D. H. Delgado, "Can HLA-G polymorphisms predict the development of cardiac allograft vasculopathy?" Human Immunology, vol. 74, no. 4, pp. 464-467, 2013.
101. S. Le Rond, J. Le Maoult, C. Creput, et al., "Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients, " European Journal of Immunology, vol. 34, no. 3, pp. 649-660, 2004.
102. C. Creput, A. Durrbach, C. Menier, et al., "Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation, " Journal of Hepatology, vol. 39, no. 4, pp. 587-594, 2003.
103. O. Brugière, G. Thabut, M. Pretolani, et al., "Immunohistochemical study of HLA-G expression in lung transplant recipients, " The American Journal of Transplantation, vol. 9, no. 6, pp. 1427-1438, 2009.
104. A. Naji, S. Le Rond, A. Durrbach, et al., "CD3+CD4 low and CD3 +CD8 loware induced byHLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance, " Blood, vol. 110, no. 12, pp. 3936-3948, 2007.
105. V. Zarkhin, A. Talisetti, L. Li, et al., "Expression of soluble HLAG identifies favorable outcomes in liver transplant recipients, " Transplantation, vol. 90, no. 9, pp. 1000-1005, 2010.
106. B. Basturk, F. Karakayali, R. Emiroglu, et al., "Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation, " Transplantation Proceedings, vol. 38, no. 2, pp. 571-574, 2006.
107. V. Rebmann, D. Bartsch, A. Wunsch, et al., "Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation, " Human Immunology, vol. 70, no. 12, pp. 995-999, 2009.
108. H. Kaneku, "Detection of soluble HLA-G and its correlation with kidney transplant outcome, " Clinical Transplants, pp. 447-454, 2006.
109. H. Liu, Y. Chen, L. Xuan, et al., "Soluble human leukocyte antigen G molecule expression in allogeneic hematopoietic stem cell transplantation: good predictor of acute graft-versushost disease, " Acta Haematologica, vol. 130, no. 3, pp. 160-168, 2013.
110. A. LeMaux, G. Noel, B. Birebent, et al., "Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graftversus-host disease and a link with regulatory T cells, " Clinical and Experimental Immunology, vol. 152, no. 1, pp. 50-56, 2008.
111. M. Waterhouse, J. Duque-Afonso, R. Wasch, H. Bertz, and J. Finke, "Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantation, " Transplantation Proceedings, vol. 45, no. 1, pp. 397-401, 2013.
112. K. vanderVenand C. Ober, "HLA-Gpolymorphisms inAfrican Americans, " Journal of Immunology, vol. 153, no. 12, pp. 5628-5633, 1994.
113. M. Le Discorde, C. Le Danff, P. Moreau, N. Rouas-Freiss, and E. D. Carosella, "HLA-G∗0105N null allele encodes functional HLA-G isoforms, " Biology of Reproduction, vol. 73, no. 2, pp. 280-288, 2005.
114. J. Lajoie, A. Boivin, A. Jeanneau, M. Faucher, and M. Roger, "Identification of six new HLA-G alleles with non-coding DNA base changes, " Tissue Antigens, vol. 73, no. 4, pp. 379-380, 2009.
115. C. Matte, J. Lacaille, L. Zijenah, et al., "HLA-G and HLA-E polymorphisms in an indigenous african population, " Human Immunology, vol. 61, no. 11, pp. 1150-1156, 2000.
116. A. Abbas, P. Tripathi, S. Naik, and S. Agrawal, "Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions, " European Journal of Immunogenetics, vol. 31, no. 6, pp. 275-278, 2004.
117. E. A. Donadi, E. C. Castelli, A. Arnaiz-Villena, M. Roger, D. Rey, and P. Moreau, "Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association, " Cellular and Molecular Life Sciences, vol. 68, no. 3, pp. 369-395, 2011.
118. C. Czarnecki, G. Van Domselaar, J. Embree, R. Brunham, F. A. Plummer, and M. Luo, "Identification of HLA-G∗01:17, a new allele possibly generated by an interloci gene conversion event involving exon 3 of HLA-B, " Human Immunology, vol. 72, pp. 238-240, 2011.
119. J. Roger, M.-C. Faucher, and M. Roger, "Identification of a new HLA-G allele, HLA-G01:18, in a Canadian Caucasian individual, " Tissue Antigens, vol. 80, no. 5, pp. 472-473, 2012.
120. I. Cervera, M. A. Herraiz, A. Roman, J. Vidart, and J. Martinez-Laso, "The novel HLA-G∗01010302 allele differs from G∗01010301 by a single nucleotide change in intron 5, " Tissue Antigens, vol. 74, no. 5, pp. 463-464, 2009.
121. I. Cervera, M. A. Herraiz, J. Penaloza, J. Vidart, and J. Martinez-Laso, "The novel HLA-G∗01:03:01:02 allele differs from G01:03:01:01 by a possible inversion event in intron 3, " Tissue Antigens, vol. 78, no. 2, pp. 159-160, 2011.
122. A. Roman, I. Cervera, M. A. Herraiz, J. Vidart, and J. Martinez-Laso, "A new allele, HLA-G∗01010106, with changes in intron 2, " Tissue Antigens, vol. 74, pp. 270-271, 2009.
123. V. Rebmann, K. van derVen, M. Paler, K. Pfeiffer, D. Krebs, and H. Grosse-Wilde, "Association of soluble HLA-G plasma levels with HLA-G alleles, " Tissue Antigens, vol. 57, no. 1, pp. 15-21, 2001.
124. G. Mueller-Eckhardt, P. Mallmann, J. Neppert, et al., "Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortions, " Journal of Reproductive Immunology, vol. 27, no. 2, pp. 95-109, 1994.
125. C. L. Aldrich, M. D. Stephenson, T. Karrison, et al., "HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage, " Molecular Human Reproduction, vol. 7, no. 12, pp. 1167-1172, 2001.
126. A. Pirri, F. C. Contieri, R. Benvenutti, and M. D. G. Bicalho, "A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors, " Transplant Immunology, vol. 20, no. 3, pp. 143-149, 2009.
127. T. V. F. Hviid, R. Rizzo, L. Melchiorri, M. Stignani, and O. R. Baricordi, "Polymorphism in the 5 Upstream Regulatory and 3 Untranslated Regions of theHLA-GGene in Relation to Soluble HLA-G and IL-10 Expression, " Human Immunology, vol. 67, no. 1-2, pp. 53-62, 2006.
128. E. C. Castelli, C. T. Mendes-Junior, N. H. S. Deghaide, et al., "The genetic structure of 3untranslated region of the HLA-G gene: polymorphisms and haplotypes, " Genes & Immunity, vol. 11, no. 2, pp. 134-141, 2010.
129. S. J. P. Gobin, V. Keijsers, C. Cheong, M. van Zutphen, and P. J. van den Elsen, "Transcriptional regulation of HLA-G, " Transplantation Proceedings, vol. 31, no. 4, pp. 1857-1859, 1999.
130. C. Solier, V. Mallet, F. Lenfant, A. Bertrand, A. Huchenq, and P. Le Bouteiller, "HLA-G unique promoter region: functional implications, " Immunogenetics, vol. 53, no. 8, pp. 617-625, 2001.
131. Z. Tan, A. M. Shon, and C. Ober, "Evidence of balancing selection at the HLA-G promoter region, " Human Molecular Genetics, vol. 14, no. 23, pp. 3619-3628, 2005.
132. T. V. F. Hviid, S. Hylenius, C. Robye, and L. G. Nielsen, "HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels, " Immunogenetics, vol. 55, no. 2, pp. 63-79, 2003.
133. C. Ober, C. L. Aldrich, I. Chervoneva, et al., "Variation in the HLA-G promoter region influences miscarriage rates, " The American Journal of Human Genetics, vol. 72, no. 6, pp. 1425-1435, 2003.
134. D. S. Berger, W. A. Hogge, M. M. Barmada, and R. E. Ferrell, "Comprehensive analysis of HLA-G: implications for recurrent spontaneous abortion, " Reproductive Sciences, vol. 17, no. 4, pp. 331-338, 2010.
135. M. K. Misra, S. Prakash, R. Kapoor, S. K. Pandey, R. K. Sharma, and S. Agrawal, "Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease, " Tissue Antigens, vol. 82, pp. 317-326, 2013.
136. G. A. Harrison, K. E. Humphrey, I. B. Jakobsen, and D. W. Cooper, "A 14 bp deletion polymorphism in the HLA-G gene, " Human Molecular Genetics, vol. 2, no. 12, article 2200, 1993.
137. P. Rousseau, M. le Discorde, G. Mouillot, C. Marcou, E. D. Carosella, and P. Moreau, "The 14 bp deletion-insertion polymorphism in the 3 UT region of the HLA-G gene influences HLA-G mRNA stability, " Human Immunology, vol. 64, no. 11, pp. 1005-1010, 2003.
138. D. Auboeuf, A. Honig, S. M. Berget, and B. W. OMalley, "Coordinate regulation of transcription and splicing by steroid receptor coregulators, " Science, vol. 298, no. 5592, pp. 416-419, 2002.
139. S. G. Svendsen, B. M. Hantash, L. Zhao, et al., "The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3-untranslated region, " Human Immunology, vol. 74, no. 7, pp. 818-827, 2013.
140. T. V. F. Hviid, R. Rizzo, O. B. Christiansen, L. Melchiorri, A. Lindhard, and O. R. Baricordi, "HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms, " Immunogenetics, vol. 56, no. 3, pp. 135-141, 2004.
141. T. V. Hviid, S. Hylenius, A. M. Hoegh, C. Kruse, and O. B. Christiansen, "HLA-G polymorphisms in couples with recurrent spontaneous abortions, " Tissue Antigens, vol. 60, no. 2, pp. 122-132, 2002.
142. X. Wang, W. Jiang, and D. Zhang, "Association of 14-bp insertion/deletion polymorphism of HLA-G gene with unexplained recurrent spontaneous abortion: a meta-analysis, " Tissue Antigens, vol. 81, no. 2, pp. 108-115, 2013.
143. W. Fan, S. Li, Z. Huang, and Q. Chen, "Relationship between HLA-G polymorphism and susceptibility to recurrent miscarriage: a meta-analysis of non-family-based studies, " Journal of Assisted Reproduction and Genetics, vol. 31, no. 2, pp. 173-184, 2014.
144. G. Martelli-Palomino, J. A. Pancotto, Y. C. Muniz, et al., "Polymorphic sites at the 3 untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population, " PLoS ONE, vol. 8, Article ID e71742, 2013.
145. M. I. Torres, J. Luque, P. Lorite, et al., "14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring, " Human Immunology, vol. 70, no. 10, pp. 830-835, 2009.
146. T. Twito, J. Joseph, A. Mociornita, V. Rao, H. Ross, and D. H. Delgado, "The 14-bp deletion in theHLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients, " The Journal of Heart and Lung Transplantation, vol. 30, no. 7, pp. 778-782, 2011.
147. G. La Nasa, R. Littera, F. Locatelli, et al., "The human leucocyte antigen-G 14-basepair polymorphism correlates with graftversus-host disease in unrelated bone marrow transplantation for thalassaemia, " The British Journal of Haematology, vol. 139, no. 2, pp. 284-288, 2007.
148. P. Chiusolo, S. Bellesi, N. Piccirillo, et al., "Therole of HLA-G14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis, " Bone Marrow Transplantation, vol. 47, no. 1, pp. 120-124, 2012.
149. W. Boukouaci, M. Busson, C. Fortier, et al., "AssociationofHLAG low expressor genotype with severe acute graft-versus-host disease after sibling bone marrow transplantation, " Frontiers in Immunology, vol. 2, article 74, 2011.
150. F. Sizzano, M. Testi, L. Zito, et al., "Genotypes and haplotypes in the 3 untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia, " Tissue Antigens, vol. 79, no. 5, pp. 326-332, 2012.
151. Z. Tan, G. Randall, J. Fan, et al., "Allele-specific targeting of microRNAs to HLA-G and risk of asthma, " The American Journal of Human Genetics, vol. 81, no. 4, pp. 829-834, 2007.
152. T. D. Veit and J. A. B. Chies, "Tolerance versus immune response-microRNAs as important elements in the regulation of theHLA-Ggene expression, " Transplant Immunology, vol. 20, no. 4, pp. 229-231, 2009.
153. S.-M. Yie, L.-H. Li, R. Xiao, and C. L. Librach, "A single base-pair mutation in the 3-untranslated region of HLA-G mRNA is associated with pre-eclampsia, " Molecular Human Reproduction, vol. 14, no. 11, pp. 649-653, 2008.
154. E. C. Castelli, P. Moreau, A. O. E. Chiromatzo, et al., "In silico analysis of microRNAS targeting the HLA-G 3 untranslated region alleles and haplotypes, " Human Immunology, vol. 70, no. 12, pp. 1020-1025, 2009.
155. D. C. Cilião Alves, J. C. De Oliveira Crispim, E. C. Castelli, et al., "Human leukocyte antigen-G 3 untranslated region polymorphisms are associated with better kidney allograft acceptance, " Human Immunology, vol. 73, no. 1, pp. 52-59, 2012.
156. S. J. P. Gobin and P. J. van den Elsen, "Transcriptional regulation of theMHC class Ib genes HLA-E, HLA-F and HLA-G, " Human Immunology, vol. 61, no. 11, pp. 1102-1107, 2000.
157. S. Flajollet, I. Poras, E. D. Carosella, and P. Moreau, "RREB-1 is a transcriptional repressor of HLA-G, " Journal of Immunology, vol. 183, no. 11, pp. 6948-6959, 2009.
158. P. Moreau, G. Mouillot, P. Rousseau, C. Marcou, J. Dausset, and E. D. Carosella, "HLA-G gene repression is reversed by demethylation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1191-1196, 2003.
159. G. Mouillot, C. Marcou, P. Rousseau, N. Rouas-Freiss, E. D. Carosella, and P. Moreau, "HLA-G gene activation in tumor cells involves cis-acting epigenetic changes, " International Journal of Cancer, vol. 113, no. 6, pp. 928-936, 2005.
160. K. Polakova, E. Bandzuchova, J. Tirpakova, D. Kuba, and G. Russ, "Modulation of HLA-G expression, " Neoplasma, vol. 54, no. 6, pp. 455-462, 2007.
161. T. M. Holling, M. W. T. Bergevoet, R. J. Wierda, M. C. J. A. van Eggermond, and P. J. van den Elsen, "Genetic and epigenetic control of the major histocompatibility complex class Ib Gene HLA-G in Trophoblast cell lines, " Annals of the New York Academy of Sciences, vol. 1173, pp. 538-544, 2009.
162. I. Manaster, D. Goldman-Wohl, C. Greenfield, et al., "MiRNAmediated control of HLA-G expression and function, " PLoS ONE, vol. 7, no. 3, Article ID e33395, 2012.
163. S. M. Yie, R. Xiao, and C. L. Librach, "Progesterone regulates HLA-G gene expression through a novel progesterone response element, " Human Reproduction, vol. 21, no. 10, pp. 2538-2544, 2006.
164. S. Yie, L. Li, G. Li, R. Xiao, and C. L. Librach, "Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro, " Human Reproduction, vol. 21, no. 1, pp. 46-51, 2006.
165. D. S. Kyurkchiev, E. Ivanova-Todorova, and S. D. Kyurkchiev, "Effect of progesterone on human mesenchymal stem cells, " Vitamins and Hormones, vol. 87, pp. 217-237, 2011.
166. R. Sheshgiri, V. Rao, L. C. Tumiati, et al., "Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells., " Circulation, vol. 118, no. 14, pp. S58-S64, 2008.
167. G. Mouillot, C. Marcou, I. Zidi, et al., "HypoxiamodulatesHLAG gene expression in tumor cells, " Human Immunology, vol. 68, no. 4, pp. 277-285, 2007.
168. Y. Yang, D. E. Geraghty, and J. S. Hunt, "Cytokine regulation of HLA-G expression in human trophoblast cell lines, " Journal of Reproductive Immunology, vol. 29, no. 3, pp. 179-195, 1995.
169. P. Moreau, F. Adrian-Cabestre, C. Menier, et al., "IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes, " International Immunology, vol. 11, no. 5, pp. 803-811, 1999.
170. P. Moreau, S. Flajollet, and E. D. Carosella, "Non-classical transcriptional regulation of HLA-G: an update, " Journal of Cellular and Molecular Medicine, vol. 13, no. 9, pp. 2973-2989, 2009.
171. S. Lefebvre, S. Berrih-Aknin, F. Adrian, et al., "A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-β, " The Journal of Biological Chemistry, vol. 276, no. 9, pp. 6133-6139, 2001.
172. V. Rebmann, J. Regel, D. Stolke, and H. Grosse-Wilde, "Secretion of sHLA-G molecules inmalignancies, " Seminars in Cancer Biology, vol. 13, no. 5, pp. 371-377, 2003.
173. S. Ugurel, V. Rebmann, S. Ferrone, W. Tilgen, H. Grosse-Wilde, and U. Reinhold, "Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy, " Cancer, vol. 92, pp. 369-376, 2001.
174. P. Cadet, P. L. Rady, S. K. Tyring, R. B. Yandell, and T. K. Hughes, "Interleukin-10 messenger ribonucleic acid in human placenta: implications of a role for interleukin-10 in fetal allograft protection, " The American Journal of Obstetrics and Gynecology, vol. 173, no. 1, pp. 25-29, 1995.
175. S. Zilberman, C. Schenowitz, S. Agaugue, et al., "HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment, " European Journal of Immunology, vol. 42, no. 6, pp. 1599-1608, 2012.
176. P. Moreau, O. Faure, S. Lefebvre, et al., "Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts, " Transplantation Proceedings, vol. 33, no. 3, pp. 2277-2280, 2001.
177. A. Akhter, R. M. Faridi, V. Das, A. Pandey, S. Naik, and S. Agrawal, "In vitro up-regulation of HLA-G using dexamethasone and hydrocortisone in first-trimester trophoblast cells of women experiencing recurrent miscarriage, " Tissue Antigens, vol. 80, no. 2, pp. 126-135, 2012.
178. A. Akhter, V. Das, S. Naik, R. M. Faridi, A. Pandey, and S. Agrawal, "Upregulation of HLA-G in JEG-3 cells by dexamethasone and hydrocortisone, " Archives of Gynecology and Obstetrics, vol. 285, no. 1, pp. 7-14, 2012.
179. R. Sheshgiri, F. Gustafsson, J. Sheedy, V. Rao, H. J. Ross, and D. H. Delgado, "Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients, " Journal of Heart and Lung Transplantation, vol. 28, no. 11, pp. 1193-1197, 2009.
180. R. Bahri, A. Naji, C. Menier, et al., "Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance, " Journal of Immunology, vol. 183, no. 11, pp. 7054-7062, 2009.
181. G. Stallone, P. Pontrelli, B. Infante, et al., "Rapamycin induces ILT3ILT4 dendritic cells promoting a new immunoregulatory pathway, " Kidney International, vol. 85, no. 4, pp. 888-897, 2014.
182. B. Fedoric and R. Krishnan, "Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction, " Immunology Letters, vol. 120, no. 1-2, pp. 49-56, 2008.
183. J. LeMaoult, M. Daouya, J. Wu, M. Loustau, A. Horuzsko, and E. D. Carosella, "Synthetic HLA-G proteins for therapeutic use in transplantation, " FASEB Journal, vol. 27, no. 9, pp. 3643-3651, 2013.
184. M. F. Pittenger, A. M. Mackay, S. C. Beck, et al., "Multilineage potential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
185. M. Mathieu, J. Bartunek, B. El Oumeiri, et al., "Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction, " Journal of Thoracic and Cardiovascular Surgery, vol. 138, no. 3, pp. 646-653, 2009.
186. A. Naji, N. Rouas-Freiss, A. Durrbach, E. D. Carosella, L. Sensebe, and F. Deschaseaux, "Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy, " Stem Cells, vol. 31, no. 11, pp. 2296-2303, 2013.
187. M. Shi, Z.-W. Liu, and F.-S. Wang, "Immunomodulatory properties and therapeutic application of mesenchymal stem cells, " Clinical & Experimental Immunology, vol. 164, no. 1, pp. 1-8, 2011.
188. Z. Selmani, A. Naji, I. Zidi, et al., "Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte andnatural killer functionand to induce CD4+ CD25highFOXP3+ regulatory T cells, " StemCells, vol. 26, no. 1, pp. 212-222, 2008.
189. K. Le Blanc, I. Rasmusson, B. Sundberg, et al., "Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, " The Lancet, vol. 363, no. 9419, pp. 1439-1441, 2004.
190. F. Baron and R. Storb, "Mesenchymal stromal cells: a new tool against graft-versus-host disease?" Biology of Blood andMarrow Transplantation, vol. 18, no. 6, pp. 822-840, 2012.
191. B. Zhang, Y. Yin, R. C. Lai, S. S. Tan, A. B. Choo, and S. K. Lim, "Mesenchymal stem cells secrete immunologically active exosomes, " Stem Cells and Development, vol. 23, no. 11, pp. 1233-1244, 2014.
192. A. V. Vlassov, S. Magdaleno, R. Setterquist, and R. Conrad, "Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials, " Biochimica et Biophysica Acta, vol. 1820, no. 7, pp. 940-948, 2012.
193. L. Kordelas, V. Rebmann, A. K. Ludwig, et al., "MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versushost disease, " Leukemia, 2014.